Sexual health

Expedited Partner Therapy — Treating Your Partner Without a Visit

Save

Treating one person for chlamydia or gonorrhea while their partner goes untreated is how these infections bounce back and forth. Expedited partner therapy solves that by letting a provider prescribe for a partner they have never examined. It is endorsed for specific bacterial STIs, permitted in most states, and paired with a simple message: the partner should still get tested when they can.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What is expedited partner therapy?

Expedited partner therapy — EPT — is the practice of treating the sex partners of a person diagnosed with an STI by giving the patient a prescription or medication to deliver to the partner, without the partner first being examined by a clinician 1. The CDC defines it and recommends that providers routinely offer it for chlamydia and gonorrhea when a patient's partners are unlikely to seek timely care on their own 1.

The problem it solves. After someone is treated, their recent partners often remain infected. Some will not, or cannot, get to a clinic quickly — no insurance, no time, embarrassment, or distance. EPT removes the visit as a barrier so the partner gets treated before they pass the infection back.

What 'expedited' means. It is faster than the usual route because it skips the partner's own appointment. The guideline frames it for partners from roughly the previous 60 days 1. It is a public-health tool as much as a personal one: treating both people at once is what actually clears an infection from a couple, rather than passing it back and forth.

Why treat a partner you can't bring in?

Because reinfection is the default without it. Chlamydia is common, frequently silent, and easily passed back and forth: a person can be cured, then catch it again from an untreated partner within weeks — a pattern often called ping-pong reinfection 2. Treating only one half of a couple rarely holds, which is the entire reason partner treatment matters.

Why chlamydia is the classic case. Chlamydia often causes no symptoms, so an untreated partner has no reason to seek care and no idea they are still carrying it. Left untreated, it can lead to pelvic inflammatory disease and infertility in women 2. The infection keeps circulating precisely because it is invisible.

The scale of it. More than 2.4 million cases of chlamydia, gonorrhea, and syphilis were reported in the United States in 2023, with chlamydia the most reported of the three 3. At that volume, reinfection is not a rare edge case — it is a routine failure mode, and EPT was built to prevent it.

An STI is a two-person problem. Treating one person and skipping the partner is the most common way these infections come back.

Which STIs is EPT used for?

Mainly chlamydia and gonorrhea. The CDC recommendation for EPT is specific to those two bacterial infections, which are curable with antibiotics and which spread readily between partners 14. Both are also frequently symptom-free, so a partner often has no prompt to seek care on their own — exactly the situation EPT is meant for.

Not a fit for every STI. The clearest evidence and the CDC recommendation are for chlamydia and gonorrhea 1. Other infections — syphilis, HIV — need their own evaluation and follow-up that a passed-along prescription cannot provide. Syphilis in particular requires staging and monitoring, and HIV requires its own testing and care.

Where it sits among the tools. EPT treats an infection that already happened; it is not prevention like condoms or doxy-pep. Chlamydia and gonorrhea are also reportable stis, meaning diagnoses are counted by public-health authorities — one reason partner treatment is treated as a shared responsibility rather than only a private matter.

How EPT works in practice

In practice, the clinician either writes a prescription for the partner or dispenses the medication directly to the patient, together with written information for the partner 1. The patient carries it to the partner. The medication is the standard oral regimen for chlamydia or gonorrhea drawn from the treatment guidelines — no injection, no visit required 4.

What comes with it. Good EPT includes an information sheet: what the medication is, how it is taken, which allergic reactions to watch for, and a clear recommendation that the partner still see a clinician if they have symptoms, are pregnant, or have any complicating factor 1. That sheet is not a formality — it is how a partner who never saw a provider gets the warnings a visit would have given.

Cost and pharmacy. Because it is a real prescription, it moves through a pharmacy like any other, and the cost varies with insurance and the specific medication. A clinic offering EPT can explain what to expect for a given state and drug, including options if the partner is uninsured.

Some states attach conditions. Even where EPT is legal, a state may set requirements — for example, expecting the prescription to carry the partner's name where it is known, or limiting which infections it covers. A clinician practicing there knows the local rules, which is another reason EPT runs through a provider rather than around one 5.

The awkward part: telling a partner

The hardest part of EPT is often not medical but personal: telling a partner they were exposed to an STI. EPT does not remove that conversation, but it changes what you can offer at the end of it — not just 'you should get checked,' but an actual treatment in hand 1. That shift, from a request to a solution, is a large part of why partners who would never have made an appointment end up treated.

A few things that make it easier. Being direct and non-accusatory tends to land better than a long buildup. STIs pass between people without anyone doing anything wrong, and framing it as shared health rather than blame keeps the focus where it belongs — on getting both people treated. It also helps to say plainly that chlamydia and gonorrhea are common and curable 2.

If a direct conversation is not safe or possible. Some people cannot, or should not, contact a partner themselves. Health departments can sometimes help notify a partner confidentially, and a clinic can explain what is available locally alongside or instead of EPT. The two approaches are not mutually exclusive.

What to pass along with the medicine. However the conversation goes, the partner needs the written information that comes with EPT — what the medication treats, how it is taken, the allergy warnings, and the clear note to see a clinician if they have symptoms or are pregnant 1.

What EPT does not do

EPT treats a specific infection in a partner; it does not stand in for that partner's full care. It does not test the partner for other STIs, including HIV and syphilis, which a diagnosis of chlamydia or gonorrhea should prompt 1. It does not evaluate symptoms, and it does not safely cover a partner who is pregnant or seriously ill without a visit.

When the partner really should be seen. If the partner has symptoms — discharge, pelvic pain, testicular pain, a sore — or is pregnant, an in-person evaluation is the safer route even where EPT is legal 1. EPT is designed for the common case: an asymptomatic partner who otherwise would not get treated at all.

Not a substitute for your own follow-up. The person originally diagnosed still needs their own retesting and, where relevant, screening for other infections. Treating the partner protects the couple; it does not close out either person's individual care.

After EPT: retesting and preventing reinfection

Treatment is not the last step. Guidelines advise retesting about three months after treatment for chlamydia or gonorrhea, because reinfection — not treatment failure — is the usual reason an infection reappears 4. Retesting catches a partner who was missed or a new exposure that happened afterward.

Screening on a schedule, too. Separately from any single episode, the USPSTF recommends routine screening for chlamydia and gonorrhea in sexually active women 24 and younger, and in older women at increased risk 6. EPT handles the immediate partner; regular screening handles the exposures no one knew about.

The through-line. The reason EPT exists is that treating one person and skipping the partner is the single most common way these infections persist. Whether through EPT or a partner's own visit, both people getting treated around the same time — and staying off sex until treatment is complete — is what actually ends the cycle.

A note on timing. Waiting until treatment has finished, and until any single-dose regimen has had time to work, before resuming sex is part of what makes treatment hold; going back too soon is a common way a just-cleared infection returns 4. The retest a few months later is the backstop that catches the cases where that did not hold, so it is worth keeping even when everyone feels fine 4.

Common questions

EPT is legal in the large majority of U.S. states plus Washington, D.C., but the status varies and rules change. The CDC keeps a public, state-by-state legal-status page for EPT that clinicians rely on. Looking up your own state there gives a current answer, rather than trusting a figure that may be outdated.

Mainly chlamydia and gonorrhea. Those are the two bacterial infections the CDC recommendation covers, because they are curable with antibiotics and often symptom-free in a partner. Other infections, such as syphilis and HIV, need their own testing, staging, and follow-up that a passed-along prescription cannot provide.

Ideally, yes — especially if the partner has symptoms, is pregnant, or has a known drug allergy. EPT is built for the common case of an asymptomatic partner who otherwise would not get care. A partner who can be seen benefits from testing for other STIs, which EPT does not do.

It helps by treating the partner who would otherwise pass the infection back, which is the main cause of reinfection. It is not a guarantee. Guidelines still advise retesting about three months after treatment, and avoiding sex until both people have finished treatment lowers the chance of bouncing it back.

It is a real prescription filled at a pharmacy, so the cost depends on insurance and the specific medication. Some clinics and health departments can help with cost, and a provider offering EPT can explain the options for a given state and drug, including routes for a partner who is uninsured.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

EPT treats a partner — it does not replace their own care

  • A partner who is pregnant, or who has symptoms such as discharge, pelvic pain, testicular pain, or a genital sore — situations that need an in-person evaluation, not only a passed-along prescription
  • A known severe antibiotic allergy in the partner — taking a medication given without an exam can trigger a dangerous reaction
  • Ongoing symptoms in yourself after treatment — fever, worsening pelvic or lower-abdominal pain, or pain during sex, which can signal pelvic inflammatory disease

Signs of a severe allergic reaction to any medication — trouble breathing, swelling of the face or throat, or widespread hives — are an emergency; call 911 or go to an emergency room.

This article explains expedited partner therapy in general terms and is not medical advice. Whether EPT is available and appropriate depends on your diagnosis, your state's laws, and your partner's health. A licensed clinician can determine what fits your situation.

References

  1. 1.Centers for Disease Control and Prevention (2021). Expedited Partner Therapy. CDC STI Treatment Guidelines, 2021. linkThe CDC definition of expedited partner therapy and the recommendation to offer it for chlamydia and gonorrhea (partners from the previous 60 days) when partners are unlikely to seek timely care, unless prohibited by law; and that a partner with symptoms or complicating factors should be evaluated in person.
  2. 2.Centers for Disease Control and Prevention (2024). About Chlamydia. CDC (cdc.gov/chlamydia). linkThat chlamydia is a common, frequently asymptomatic, curable bacterial STI that can cause pelvic inflammatory disease and infertility if untreated — the basis for the reinfection ('ping-pong') rationale.
  3. 3.Centers for Disease Control and Prevention (2025). National Overview of STIs in 2023. CDC STI Statistics (Sexually Transmitted Infections Surveillance, 2023). linkThe 2023 U.S. surveillance figures — more than 2.4 million reported chlamydia, gonorrhea, and syphilis cases, chlamydia the most reported — establishing the scale of the reinfection problem.
  4. 4.Workowski KA, Bachmann LH, Chan PA, et al. (Centers for Disease Control and Prevention) (2021). Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recommendations and Reports, Vol. 70, No. 4. doi:10.15585/mmwr.rr7004a1The 2021 STI treatment guidelines as the source of record for the recommended oral regimens for chlamydia and gonorrhea and for retesting about three months after treatment.
  5. 5.Centers for Disease Control and Prevention (2024). Legal Status of Expedited Partner Therapy (EPT). CDC (cdc.gov/sti). linkThe CDC state-by-state legal-status map for EPT, and that EPT is permissible in the large majority of U.S. states plus DC while status varies by jurisdiction.
  6. 6.US Preventive Services Task Force (2021). Chlamydia and Gonorrhea: Screening. US Preventive Services Task Force (final recommendation, JAMA 2021). linkThe 2021 USPSTF recommendation to screen for chlamydia and gonorrhea in sexually active women 24 and younger and in older women at increased risk.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy